281 related articles for article (PubMed ID: 36163209)
1. Modelling urea cycle disorders using iPSCs.
Duff C; Baruteau J
NPJ Regen Med; 2022 Sep; 7(1):56. PubMed ID: 36163209
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for urea cycle defects: An update from historical perspectives to future prospects.
Duff C; Alexander IE; Baruteau J
J Inherit Metab Dis; 2024 Jan; 47(1):50-62. PubMed ID: 37026568
[TBL] [Abstract][Full Text] [Related]
3. Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan.
Kido J; Matsumoto S; Häberle J; Inomata Y; Kasahara M; Sakamoto S; Horikawa R; Tanemura A; Okajima H; Suzuki T; Nakamura K
J Inherit Metab Dis; 2021 Nov; 44(6):1311-1322. PubMed ID: 34232532
[TBL] [Abstract][Full Text] [Related]
4. Primary hyperammonaemia: Current diagnostic and therapeutic strategies.
Häberle J
J Mother Child; 2020 Oct; 24(2):32-38. PubMed ID: 33179600
[TBL] [Abstract][Full Text] [Related]
5. Gene Editing Correction of a Urea Cycle Defect in Organoid Stem Cell Derived Hepatocyte-like Cells.
Zabulica M; Jakobsson T; Ravaioli F; Vosough M; Gramignoli R; Ellis E; Rooyackers O; Strom SC
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530582
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
[TBL] [Abstract][Full Text] [Related]
7. Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders.
Wattanapanitch M
Stem Cells Int; 2019; 2019():5171032. PubMed ID: 31191673
[TBL] [Abstract][Full Text] [Related]
8. Urea-cycle disorders as a paradigm for inborn errors of hepatocyte metabolism.
Mian A; Lee B
Trends Mol Med; 2002 Dec; 8(12):583-9. PubMed ID: 12470992
[TBL] [Abstract][Full Text] [Related]
9. Ammonia toxicity and its prevention in inherited defects of the urea cycle.
Walker V
Diabetes Obes Metab; 2009 Sep; 11(9):823-35. PubMed ID: 19531057
[TBL] [Abstract][Full Text] [Related]
10. Functional genomics in stroke: current and future applications of iPSCs and gene editing to dissect the function of risk variants.
Granata A
BMC Cardiovasc Disord; 2023 Apr; 23(1):223. PubMed ID: 37120540
[TBL] [Abstract][Full Text] [Related]
11. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical Research for Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cell and Genome Editing Technologies.
Yamashita T; Takayama K; Hori M; Harada-Shiba M; Mizuguchi H
Biol Pharm Bull; 2019; 42(3):312-318. PubMed ID: 30828061
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome and intervention of urea cycle disorders in Japan.
Kido J; Nakamura K; Mitsubuchi H; Ohura T; Takayanagi M; Matsuo M; Yoshino M; Shigematsu Y; Yorifuji T; Kasahara M; Horikawa R; Endo F
J Inherit Metab Dis; 2012 Sep; 35(5):777-85. PubMed ID: 22167275
[TBL] [Abstract][Full Text] [Related]
14. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
[TBL] [Abstract][Full Text] [Related]
15. Liver involvement in urea cycle disorders: a review of the literature.
Bigot A; Tchan MC; Thoreau B; Blasco H; Maillot F
J Inherit Metab Dis; 2017 Nov; 40(6):757-769. PubMed ID: 28900784
[TBL] [Abstract][Full Text] [Related]
16. Progress and challenges in development of new therapies for urea cycle disorders.
Soria LR; Ah Mew N; Brunetti-Pierri N
Hum Mol Genet; 2019 Oct; 28(R1):R42-R48. PubMed ID: 31227828
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of the urea cycle in widely-used hepatic cellular models.
Makris G; Veit L; Rüfenacht V; Klassa S; Zürcher N; Matsumoto S; Poms M; Häberle J
J Inherit Metab Dis; 2024 Jan; ():. PubMed ID: 38192032
[TBL] [Abstract][Full Text] [Related]
18. Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects.
Meyburg J; Hoffmann GF
Mol Genet Metab; 2010; 100 Suppl 1():S77-83. PubMed ID: 20156696
[TBL] [Abstract][Full Text] [Related]
19. Metabolically based liver damage pathophysiology in patients with urea cycle disorders - A new hypothesis.
Ivanovski I; Ješić M; Ivanovski A; Garavelli L; Ivanovski P
World J Gastroenterol; 2017 Nov; 23(44):7930-7938. PubMed ID: 29209134
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
